146 related articles for article (PubMed ID: 31759380)
1. Association between Cyclooxygenase-2 and Indoleamine 2,3-Dioxygenase Expression in Breast Cancer Patients from Pakistan.
Asghar K; Loya A; Rana IA; Abu Bakar M; Farooq A; Tahseen M; Ishaq M; Rashid MU
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3521-3525. PubMed ID: 31759380
[TBL] [Abstract][Full Text] [Related]
2. Analysis of indoleamine 2-3 dioxygenase (IDO1) expression in breast cancer tissue by immunohistochemistry.
Soliman H; Rawal B; Fulp J; Lee JH; Lopez A; Bui MM; Khalil F; Antonia S; Yfantis HG; Lee DH; Dorsey TH; Ambs S
Cancer Immunol Immunother; 2013 May; 62(5):829-37. PubMed ID: 23344392
[TBL] [Abstract][Full Text] [Related]
3. Cancer/stroma interplay via cyclooxygenase-2 and indoleamine 2,3-dioxygenase promotes breast cancer progression.
Chen JY; Li CF; Kuo CC; Tsai KK; Hou MF; Hung WC
Breast Cancer Res; 2014 Jul; 16(4):410. PubMed ID: 25060643
[TBL] [Abstract][Full Text] [Related]
4. Indoleamine 2,3-dioxygenase expression and overall survival in patients diagnosed with breast cancer in Pakistan.
Asghar K; Loya A; Rana IA; Tahseen M; Ishaq M; Farooq A; Bakar MA; Masood I
Cancer Manag Res; 2019; 11():475-481. PubMed ID: 30655699
[TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer.
Li F; Zhao Y; Wei L; Li S; Liu J
Cancer Biol Ther; 2018 Aug; 19(8):695-705. PubMed ID: 29621426
[TBL] [Abstract][Full Text] [Related]
6. Forkhead box P3 and indoleamine 2,3-dioxygenase co-expression in Pakistani triple negative breast cancer patients.
Asghar K; Loya A; Rana IA; Bakar MA; Farooq A; Tahseen M; Ishaq M; Masood I; Rashid MU
World J Clin Oncol; 2020 Dec; 11(12):1018-1028. PubMed ID: 33437664
[TBL] [Abstract][Full Text] [Related]
7. Expression of programmed cell death protein 1 (PD-1) and indoleamine 2,3-dioxygenase (IDO) in the tumor microenvironment and in tumor-draining lymph nodes of breast cancer.
Ye Q; Wang C; Xian J; Zhang M; Cao Y; Cao Y
Hum Pathol; 2018 May; 75():81-90. PubMed ID: 29447919
[TBL] [Abstract][Full Text] [Related]
8. Chemoresistance was correlated with elevated expression and activity of indoleamine 2,3-dioxygenase in breast cancer.
Zhao Y; Wei L; Liu J; Li F
Cancer Chemother Pharmacol; 2020 Jan; 85(1):77-93. PubMed ID: 31844921
[TBL] [Abstract][Full Text] [Related]
9. Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients.
Sicking I; Rommens K; Battista MJ; Böhm D; Gebhard S; Lebrecht A; Cotarelo C; Hoffmann G; Hengstler JG; Schmidt M
BMC Cancer; 2014 Dec; 14():952. PubMed ID: 25511800
[TBL] [Abstract][Full Text] [Related]
10. Analysis of indoleamine 2-3 dioxygenase (IDO) and EGFR co-expression in breast cancer tissue by immunohistochemistry.
Bi WW; Zhang WH; Yin GH; Luo H; Wang SQ; Wang H; Li C; Yan WQ; Nie DZ
Asian Pac J Cancer Prev; 2014; 15(14):5535-8. PubMed ID: 25081660
[TBL] [Abstract][Full Text] [Related]
11. High Indoleamine 2,3-Dioxygenase Is Correlated With Microvessel Density and Worse Prognosis in Breast Cancer.
Wei L; Zhu S; Li M; Li F; Wei F; Liu J; Ren X
Front Immunol; 2018; 9():724. PubMed ID: 29719533
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells.
Brandacher G; Perathoner A; Ladurner R; Schneeberger S; Obrist P; Winkler C; Werner ER; Werner-Felmayer G; Weiss HG; Göbel G; Margreiter R; Königsrainer A; Fuchs D; Amberger A
Clin Cancer Res; 2006 Feb; 12(4):1144-51. PubMed ID: 16489067
[TBL] [Abstract][Full Text] [Related]
13. Indoleamine 2,3-dioxygenase regulates T cell activity through Vav1/Rac pathway.
Li R; Li H; Sun Q; Liu L; Zhang C; Ren X
Mol Immunol; 2017 Jan; 81():102-107. PubMed ID: 27930920
[TBL] [Abstract][Full Text] [Related]
14. The Role of Indoleamine 2,3-Dioxygenase in Diethylnitrosamine-Induced Liver Carcinogenesis.
Shibata Y; Hara T; Nagano J; Nakamura N; Ohno T; Ninomiya S; Ito H; Tanaka T; Saito K; Seishima M; Shimizu M; Moriwaki H; Tsurumi H
PLoS One; 2016; 11(1):e0146279. PubMed ID: 26727596
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of COX-2 but not indoleamine 2,3-dioxygenase-1 enhances the immunosuppressive ability of human umbilical cord-derived mesenchymal stem cells.
Li D; Han Y; Zhuang Y; Fu J; Liu H; Shi Q; Ju X
Int J Mol Med; 2015 May; 35(5):1309-16. PubMed ID: 25777747
[TBL] [Abstract][Full Text] [Related]
16. Expression of cyclooxygenase-2 and 12-lipoxygenase in human breast cancer and their relationship with HER-2/neu and hormonal receptors: impact on prognosis and therapy.
Mohammad AM; Abdel HA; Abdel W; Ahmed AM; Wael T; Eiman G
Indian J Cancer; 2006; 43(4):163-8. PubMed ID: 17192687
[TBL] [Abstract][Full Text] [Related]
17. Indoleamine 2,3-dioxygenase (IDO) expression in lung cancer.
Karanikas V; Zamanakou M; Kerenidi T; Dahabreh J; Hevas A; Nakou M; Gourgoulianis KI; Germenis AE
Cancer Biol Ther; 2007 Aug; 6(8):1258-62. PubMed ID: 17700060
[TBL] [Abstract][Full Text] [Related]
18. Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer.
Zhang T; Tan XL; Xu Y; Wang ZZ; Xiao CH; Liu R
Chin Med J (Engl); 2017 Mar; 130(6):710-716. PubMed ID: 28303855
[TBL] [Abstract][Full Text] [Related]
19. High Indoleamine 2,3-Dioxygenase Expression along with Low Bridging Integrator-1 Expression in Hepatocellular Carcinoma Patients.
Asghar K; Rana IA; Abubakar M; Hasham K; Tahseen M; Bilal S; Mehmood S; Farooq A; Siddique K; Loya A
Asian Pac J Cancer Prev; 2023 May; 24(5):1591-1600. PubMed ID: 37247278
[TBL] [Abstract][Full Text] [Related]
20. Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model.
Hanihara M; Kawataki T; Oh-Oka K; Mitsuka K; Nakao A; Kinouchi H
J Neurosurg; 2016 Jun; 124(6):1594-601. PubMed ID: 26636389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
